Stay up to date with the latest news about our innovation initiatives

Published on 20/05/2022

Innovative therapies for vitiligo

Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo

Published on 20/03/2022

Understanding hidradenitis suppurativa

Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa

Published on 20/01/2022

Glue degraders for skin diseases

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

Almirall is looking for new assets that could be used for the treatment of skin conditions such as immune-inflammatory, dermato-oncology, and rare diseases